Managing Partner of 5AM Ventures, Dr. Scott Rocklage, PhD, is the embodiment of career and educational success. Dr. Scott Rocklage had a promising academic beginning receiving his B.S. in Chemistry from the University of California. After his undergraduate experience, Dr. Scott Rocklage continued his academic career by enrolling in a PhD program at the Massachusetts Institute of Technology. It was at MIT that Dr. Scott Rocklage received his PhD in Chemistry. During his enrollment at MIT he also worked in the laboratory of Richard R. Schrock; Richard R. Schrock received the Nobel Prize in Chemistry in 2005. In later years, Dr. Scott Rocklage and his wife, Patty Rocklage, donated a generous gift to the Chemistry Department at MIT reflecting upon the positive difference his academic career at MIT made on his role as a professional and more information click here.
Dr. Rocklage, PhD, a Managing Partner at 5AM Ventures, started his career at 5AM Ventures in 2003 as a Venture Partner and quickly became Managing Partner in 2004 which is consistent with his past success in the professional field.
The professional history of Dr. Scott Rocklage is that of much accolade. He has over 30 years of healthcare management experience with numerous accomplishments which include the production of 100 peer- reviewed publications, role as inventor/co-inventor of 30 U.S. patents, and FDA approval of 3 U.S. Drug Applications: Omniscan, Teslascan, and Cubicin.
In addition, Dr. Rocklage,PhD has held leadership positions in numerous organizations. The history of his profession includes: Chairman and CEO of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar, Board Chairman of Relypsa, Novira, Rennovia, Kinestra, Cidara, Board Member of Epirus and Pulmatrix, and Executive Chairman of Illypsa, Miikana, and Sempras and learn more about Scott.
Dr. Scott Rocklage, PhD has had a long and prosperous life and career.